ROCHE HOLDING LTD - 25 Jan 2023 Form 4 Insider Report for Jasper Therapeutics, Inc. (JSPR)

Reporting relationship: 10%+ Owner
Issuer ticker: JSPR
Reported as of: 25 Jan 2023
Net transaction value: -$141,750
SEC form: 4
Accepted by SEC: 26 Jan 2023, 16:49:09 UTC
Prior SEC filing: 04 Nov 2021
Next SEC filing: 07 Nov 2023
Source filing: View source filing
Reporting owner signature: ROCHE FINANCE LTD, By: /s/ Beat Kraehenmann, Authorized Signatory

Key filing fact

ROCHE HOLDING LTD filed Form 4 for Jasper Therapeutics, Inc. (JSPR) on 26 Jan 2023.

Key facts

This page summarizes ROCHE HOLDING LTD's Form 4 filing for Jasper Therapeutics, Inc. (JSPR).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 26 Jan 2023, 16:49.

Change

Previous filing in this sequence was filed on 04 Nov 2021.
Current net transaction value: -$141,750.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

JSPR transaction

Voting Common Stock

Sale

Transaction value: $141,750
Shares: -75,000
Change %: -1.6%
Price: $1.89
Shares after: 4,549,606
Date: 25 Jan 2023
Ownership: See Footnote
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares held by Roche Finance Ltd ("Roche Finance"). Roche Finance is a wholly owned subsidiary of Roche Holding Ltd ("Roche Holding"), a Swiss corporation whose shares are traded on the SIX Swiss Exchange. Roche Holding is the indirect beneficial owner of these securities of the Issuer. This Form 4 shall not be deemed an admission that any reporting person or other person is a beneficial owner of any securities of the Issuer for any purpose, other than the securities reported in this Form 4.